| Investor Type | Firm |
| Stages | Early,Seed,Series A |
| Investing | United States |
| Investment Range | $2,000,000 - $4,000,000 |
Nameless Ventures is an early-stage technology investment fund that focuses primarily on Seed to Series A funding rounds. Based in Chicago, they are a group of entrepreneurs and investors with extensive experience in starting and operating a multitude of startups.
Nameless Ventures operates with the philosophy that even the most promising ideas that might not yet have recognition or a 'name' in the industry, deserve a chance to grow and succeed. They emphasize backing their portfolio companies in every aspect, providing more than just financial support.
Their investment range falls between $2,000,000 to $4,000,000, demonstrating a significant commitment to their chosen ventures. Nameless Ventures has a diverse portfolio that includes companies across various industries, showing their flexibility and interest in different market opportunities.
Some of the companies they have invested in are Avail, BiomeSense, Black Buffalo, CareDirect Solutions, Draftbit, Factor_, Genecis Bioindustries, GigaStar, Human Predictions, INFI, Jiobit, Kin Insurance, Mori, Nutrisense, PechaKucha, and Qualsights. This portfolio also includes successful exits, which indicates their capability to identify and nurture high-potential startups.
Their specializations in Early, Seed, and Series A stages of funding are aligned with their strategy of getting in at the ground level and assisting in the foundational growth stages of innovative tech startups.

